For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220617:nRSQ2192Pa&default-theme=true
RNS Number : 2192P Directa Plus PLC 17 June 2022
17 June 2022
Directa Plus plc
("Directa Plus" or the "Company")
AGM Trading Update
Directa Plus (AIM: DCTA), a leading producer and supplier of graphene-based
products for use in consumer and industrial markets, provides an update on the
current financial year to 31 December 2022 ahead of its Annual General Meeting
to be held later today.
As announced in the Final Results on 5 May 2022, Directa Plus was trading in
line with FY2021 during the first quarter of the year. Pleasingly, the Company
has seen an acceleration in trading in the last two months and revenue to the
end of May 2022 was €4.60 million, approximately 44% ahead of the same
period last year, driven by growth across all of its commercial
verticals, with the Company's sales in line with expectations. The Company
continues to work to mitigate inflationary pressure on costs while maintaining
increased investment in operations.
Directa Plus remains optimistic on its ability to secure a very material
contract for which it has tendered via the Company's subsidiary, Setcar, for
Environmental Remediation services. The Company now expects a decision on the
tender in early H2 2022. The contract is significantly larger than
anything secured to date and, if awarded, it is expected to commence by year
end.
The Board is encouraged by the significant progress made in the financial year
to date, with accelerated growth rates enabled by the successful fundraise at
the end of 2021. The Company's strategy to invest in high value opportunities
in key verticals remains in place, with a particular focus presently on US
markets. Directa Plus is seeing accelerated traction for Environmental
Remediation and Textiles and sees high potential for entry into international
filtration markets, paints and Lithium Sulphur batteries with blue chip
partners. The Board looks forward to updating investors on progress in due
course.
For further information please visit http://www.directa-plus.com/
(http://www.directa-plus.com/) or contact:
Directa Plus plc +39 02 36714458
Giulio Cesareo, CEO / Giorgio Bonfanti, CFO
Cenkos Securities plc (Nominated Adviser and Joint Broker) +44 131 220 6939
Neil McDonald / Adam Rae
Singer Capital Markets (Joint Broker) +44 20 7496 3069
Rick Thompson / Phil Davies
Tavistock (Financial PR and IR) +44 20 7920 3150
Simon Hudson / Heather Armstrong
About Directa Plus
Directa Plus (www.directa-plus.com) is one of the largest producers and
suppliers of graphene-based products for use in consumer and industrial
markets. The Company's graphene manufacturing capability uses proprietary
patented technology based on a plasma super expansion process. Starting from
natural graphite, each step of Directa Plus' production process - expansion,
exfoliation and drying - creates graphene-based materials and hybrid graphene
materials ready for a variety of uses and available in various forms such as
powder, liquid and paste.
This proprietary production process uses a physical process, rather than a
chemical process, to process graphite into pristine graphene nanoplatelets,
which enables Directa Plus to offer a sustainable, non-toxic product, without
unwanted by-products. Directa Plus' products are made of hybrid graphene
materials and graphene nano-platelets. The products (marketed as G+®) have
multiple applications due to its properties. These G+® products can be
categorised into various families, with different products being suitable for
specific practical applications.
Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and
has been listed on the AIM market of the London Stock Exchange since May 2016.
The Company holds the Green Economy Mark from London Stock Exchange which
recognises companies that contribute to the global green economy.
-ends-
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END AGMEAEKKFLLAEAA